EPA and DHA suppress Angll- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells

Journal of Nephrology

Volumn 22, Issue 1, 2009, Pages 137-143

  Priante, Giovanna ^a   Musacchio, Estella ^a   Valvason, Chiara ^a   Baggio, Bruno ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angiotensin II; Arachidonic acid; Mesangial cells; N 3 PUFAS; Renal fibrosis; TGF

Indexed keywords

ANGIOTENSIN II; ARACHIDONIC ACID; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; DOCOSAHEXAENOIC ACID; FIBRONECTIN; ICOSAPENTAENOIC ACID; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY FIBROSIS; MESANGIUM CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; DRUG EFFECT; FIBROSIS; KIDNEY; METABOLISM; PATHOLOGY;

ANGIOTENSIN II; ARACHIDONIC ACID; CELLS, CULTURED; COLLAGEN TYPE IV; CONNECTIVE TISSUE GROWTH FACTOR; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FIBRONECTINS; FIBROSIS; HUMANS; KIDNEY; MESANGIAL CELLS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 66349086008     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Baggio B, Musacchio E, Priante G. Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications. J Nephrol. 2005;18:362-367.
2. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71(S1):343S-348S.
3. Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids. 2003;38:343-352.
4. Yaqoob P, Calder PC. Fatty acids and immune function: new insights into mechanisms. Br J Nutr. 2007;98 Suppl 1:S41-S45.
5. Rüster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006;17:2985-2991.
6. Priante G, Bordin L, Musacchio E, Clari G, Baggio B. Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid. Clin Sci (Lond). 2002;102:403-409.
7. Schroeder A, Mueller O, Stocker S, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7:3.
8. Grande JP, Walker HJ, Holub BJ, et al. Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int. 2000;57:1027-1040.
9. Schmitz PG, Zhang K, Dalal R. Eicosapentaenoic acid suppresses PDGF-induced DNA synthesis in rat mesangial cells: involvement of thromboxane A2. Kidney Int. 2000;57:1041-1051.
10. Nitta K, Uchida K, Tsutsui T, et al. Eicosapentaenoic acid inhibits mitogen-induced endothelin-1 production and DNA synthesis in cultured bovine mesangial cells. Am J Nephrol. 1998;18:164-170.
11. Priante G, Musacchio E, Pagnin E, Calò LA, Baggio B. Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells. Clin Sci (Lond). 2005; 109:177-182.
12. Musacchio E, Priante G, Budakovic A, Baggio B. Effects of unsaturated free fatty acids on adhesion and on gene expression of extracellular matrix macromolecules in human osteoblast-like cell cultures. Connect Tissue Res. 2007;48:34-38.
13. Ray PE, Bruggeman LA, Horikoshi S, Aguilera G, Klotman PE. Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int. 1994;45:177-184.
14. Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep. 2003;5:73-79.
15. Mima A, Matsubara T, Arai H, et al. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Lab Invest. 2006;86:927-939.
16. Ji Z, Huang C, Liang C, Chen B, Chen S, Sun W. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis. Cell Mol Immunol. 2005;2:150-154.
17. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431-2437.
18. Wolf G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int. 2006;70:1914-1919.
19. Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE. Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun. 2006;339:633-641.
20. Naito T, Masaki T, Nikolic-Paterson DJ, Tanji C, Yorioka N, Kohno N. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol. 2004;286:F278-F287.
21. Motojima M, Kakuchi J, Yoshioka T. Association of TGF-beta signaling in angiotensin II-induced PAI-1 mRNA upregulation in mesangial cells: role of PKC. Biochim Biophys Acta. 1999;1449:217-226.
22. Huang Y, Noble NA, Zhang J, Xu C, Border WA. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007;72:45-52.
23. Brenner RR. Factors influencing fatty acid chain elongation and desaturation. In: Vergrossen AJ, Crawford M, eds. The role of fats in human nutrition. 2nd ed. London: Academic Press; 1989:45-79.
24. Graber R, Sumida C, Nunez EA. Fatty acids and cell signal transduction. J Lipid Mediat Cell Signal. 1994;9:91-116.
25. Kamanna VS, Bassa BV, Vaziri ND, Roh DD. Atherogenic lipoproteins and tyrosine kinase mitogenic signaling in mesangial cells. Kidney Int Suppl. 1999;71:S70-S75.
26. Bordin L, Priante G, Musacchio E, et al. Arachidonic acidinduced IL-6 expression is mediated by PKC a activation in osteoblastic cells. Biochemistry. 2003;42:4485-4491.
27. Camandola S, Leonarduzzi G, Musso T, et al. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun. 1996;229:643-647.
28. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egidio J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35:881-900.
29. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RAK, Thaiss G. Angiotensin II activates nuclear transcription factorkappaB through AT1 and AT2 receptors. Kidney Int. 2002;61:1986-1995.
30. Ozawa Y, Kobori H. Crucial role of Rho-nuclear factor-kB axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol. 2007;293:F100-F109.
31. Li XC, Zhuo JL. Nuclear factor-kB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens. 2008;17:37-43.
32. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int. 2005;67:799-812.
33. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Fitzpatrick-Wong S, Aukema HM. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease. Kidney Int. 2003;64:1214-1221.